SHARON MARIE VELEZ-MAYMI

Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism SAN JUAN, PR NPI 1982937728

General Payments — all program years on this page

$4,518.32

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 137
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $748.40 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $748.4021

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $756.7917
2019 $953.8421
2020 $315.7316
2021 $189.189
2022 $658.9727
2023 $895.4126
2024 $748.4021

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086163918 Bayer Puerto Rico Inc. $30.29 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086269902 Bayer Puerto Rico Inc. $27.16 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096943680 Novo Nordisk Inc $20.00 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097750444 Novo Nordisk Inc $24.18 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097780969 Novo Nordisk Inc $24.05 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101593413 E.R. Squibb & Sons, L.L.C. $20.06 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101593424 E.R. Squibb & Sons, L.L.C. $21.95 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101593450 E.R. Squibb & Sons, L.L.C. $115.00 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104275497 AstraZeneca Pharmaceuticals LP $24.34 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104543426 AstraZeneca Pharmaceuticals LP $96.93 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104762854 AstraZeneca Pharmaceuticals LP $25.33 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105239143 AstraZeneca Pharmaceuticals LP $23.26 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105368118 AstraZeneca Pharmaceuticals LP $2.24 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105462642 AstraZeneca Pharmaceuticals LP $21.27 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105742854 AstraZeneca Pharmaceuticals LP $24.01 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116193520 Amgen Inc. $25.41 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118262881 Boehringer Ingelheim Pharmaceuticals, Inc. $21.75 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118262883 Boehringer Ingelheim Pharmaceuticals, Inc. $23.44 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118262885 Boehringer Ingelheim Pharmaceuticals, Inc. $25.00 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127043007 Kyowa Kirin, Inc. $102.83 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147931179 REVANCE THERAPEUTICS, INC. $49.90 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.